Transjugular intrahepatic portosystemic stent-shunt and liver transplantation--how safe is the bridge?
Many of the current indications for use of transjugular intrahepatic stent-shunts are also indications for consideration of orthotopic liver transplantation. Tripathi et al. report a similar operative mortality and early graft function in a series of cases transplanted with a TIPSS compared to apparently matched controls, although a higher frequency of post-operative renal dysfunction.
Gimson
Alexander E S
AE
Hepatobiliary and Liver Transplant Unit, Addenbrookes Hospital, Cambridge CB2 2QQ, UK. alexander.gimson@addenbrookes.nhs.uk
D016022:Case-Control Studies; D005260:Female; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis / Q000401:mortality / Q000601:surgery*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D008297:Male; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000009:adverse effects / Q000379:methods*; D011379:Prognosis; D018570:Risk Assessment; D015996:Survival Rate; D016896:Treatment Outcome